rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1994-11-14
|
pubmed:abstractText |
Recent emphasis on the control of airway inflammation in asthma highlights the need for safe and effective antiinflammatory agents. Fluticasone propionate is one of the most potent antiinflammatory corticosteroids developed to date.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0091-6749
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
94
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
676-83
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7930300-Administration, Topical,
pubmed-meshheading:7930300-Adult,
pubmed-meshheading:7930300-Aerosols,
pubmed-meshheading:7930300-Androstadienes,
pubmed-meshheading:7930300-Anti-Inflammatory Agents,
pubmed-meshheading:7930300-Asthma,
pubmed-meshheading:7930300-Double-Blind Method,
pubmed-meshheading:7930300-Female,
pubmed-meshheading:7930300-Glucocorticoids,
pubmed-meshheading:7930300-Humans,
pubmed-meshheading:7930300-Hypothalamo-Hypophyseal System,
pubmed-meshheading:7930300-Male,
pubmed-meshheading:7930300-Patients,
pubmed-meshheading:7930300-Physicians,
pubmed-meshheading:7930300-Pituitary-Adrenal System,
pubmed-meshheading:7930300-Spirometry,
pubmed-meshheading:7930300-Treatment Outcome
|
pubmed:year |
1994
|
pubmed:articleTitle |
Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group.
|
pubmed:affiliation |
Allergy and Asthma Center, North Dartmouth, MA 92747.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|